Rule 19.6(c) confirmation of post-offer intentions

Rule 19.6(c) confirmation in respect of post-offer intention statements made in relation to Yourgene Health plc ("Yourgene")

Novacyt announces that, further to the completion of its recommended cash offer for the entire issued and to be issued share capital of Yourgene, which was implemented by way of a scheme of arrangement under Part 26 of the Companies Act 2006 and which became effective on 8 September 2023, it has duly confirmed in writing to The Panel on Takeovers and Mergers in accordance with the requirements of Rule 19.6(c) of the Code that Novacyt has complied with their respective post-offer intention statements made pursuant to Rules 2.7(c)(viii) and 24.2 of the Code, as detailed in its announcement of 3 July 2023 and scheme document published on 27 July 2023.